{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:59:50Z","timestamp":1785387590190,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mucocutaneous findings may provide important early clues to systemic disease. Because the skin, oral mucosa, eyes, and other visible mucosal surfaces are readily accessible during clinical examination, their careful assessment can contribute to earlier recognition of autoimmune, infectious, metabolic, endocrine, inflammatory, and malignant conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This narrative review aims to summarize clinically relevant mucocutaneous manifestations that may act as early indicators of systemic disease, with emphasis on their diagnostic significance and practical relevance for clinicians across specialties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A narrative literature review was conducted using PubMed\/MEDLINE, Scopus, Web of Science, Google Scholar, and reference list screening. Literature was selected to provide a clinically balanced overview of mucocutaneous findings associated with systemic disease, including autoimmune disorders, infectious diseases, metabolic and endocrine disorders, inflammatory conditions, and paraneoplastic syndromes. Priority was given to peer-reviewed clinical studies, reviews, consensus-based sources, and dermatology references that clarified diagnostic relevance, disease associations, or clinical implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mucocutaneous manifestations were identified across several systemic disease categories. In autoimmune disease, findings such as malar rash, photosensitivity, oral ulcers, heliotrope rash, and Gottron papules may support the diagnosis of systemic lupus erythematosus and dermatomyositis. Infectious diseases such as HIV infection and syphilis may present with oral candidiasis, oral hairy leukoplakia, mucous patches, or palmoplantar rash. Metabolic and endocrine disorders may be associated with acanthosis nigricans, eruptive xanthomas, xanthelasma, and other cutaneous markers of insulin resistance, dyslipidemia, or endocrine dysfunction. Paraneoplastic dermatoses, including necrolytic migratory erythema, malignant acanthosis nigricans, dermatomyositis, and acquired ichthyosis, may precede the diagnosis of internal malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Recognition of mucocutaneous manifestations can support earlier diagnosis of systemic disease and guide appropriate investigation. A structured clinical approach to visible dermatologic and mucosal signs may improve diagnostic accuracy, reduce delays, and promote interdisciplinary collaboration between dermatology, internal medicine, oral medicine, ophthalmology, and primary care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1828524","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:21:07Z","timestamp":1785385267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mucocutaneous manifestations as early indicators of systemic disease: a narrative review"],"prefix":"10.3389","volume":"13","author":[{"given":"Sarah Ammar","family":"Al Dhamin","sequence":"first","affiliation":[{"name":"Independent Researcher","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"AlDhamin","sequence":"additional","affiliation":[{"name":"College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaed","family":"Jaber","sequence":"additional","affiliation":[{"name":"College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"ref1","volume-title":"Andrews\u2019 Diseases of the Skin: Clinical Dermatology","author":"James","year":"2020"},{"key":"ref2","volume-title":"Dermatology","author":"Bolognia","year":"2018"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.abd.2022.09.005","article-title":"Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects","volume":"98","author":"Vale","year":"2023","journal-title":"An Bras Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3390\/jcm13082419","article-title":"The spectrum of cutaneous manifestations in lupus erythematosus","volume":"13","author":"Fija\u0142kowska","year":"2024","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.clindermatol.2006.07.001","article-title":"Dermatomyositis","volume":"24","author":"Callen","year":"2006","journal-title":"Clin Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European league against rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref8","volume-title":"StatPearls","author":"Qudsiya","year":"2023"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.21037\/atm-20-5252","article-title":"Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis","volume":"9","author":"Castillo","year":"2021","journal-title":"Ann Transl Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/ddg.15717","article-title":"Cutaneous manifestations of dermatomyositis in individuals with dark skin: a review of reported cases","volume":"23","author":"Akuffo-Addo","year":"2025","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/medicina58091214","article-title":"Oral manifestations associated with HIV\/AIDS patients","volume":"58","author":"Lomel\u00ed-Mart\u00ednez","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1601-0825.1998.tb00274.x","article-title":"Oral manifestations of HIV in a southeast USA population","volume":"4","author":"Patton","year":"1998","journal-title":"Oral Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1902\/jop.1995.66.1.30","article-title":"The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users","volume":"66","author":"Grbic","year":"1995","journal-title":"J Periodontol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40257-022-00755-3","article-title":"Syphilis in dermatology: recognition and management","volume":"24","author":"Whiting","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/bmj.39085.518148.BE","article-title":"Syphilis","volume":"334","author":"French","year":"2007","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3390\/diagnostics12102519","article-title":"Acanthosis nigricans: pointer of endocrine entities","volume":"12","author":"Radu","year":"2022","journal-title":"Diagnostics"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3889\/oamjms.2019.258","article-title":"Acanthosis nigricans: a two-sided coin","volume":"7","author":"Wollina","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"ref18","volume-title":"GeneReviews","author":"Ison","year":"2025"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jacl.2018.03.087","article-title":"Severe xanthomatosis in heterozygous familial hypercholesterolemia","volume":"12","author":"Aljenedil","year":"2018","journal-title":"J Clin Lipidol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ccl.2015.01.001","article-title":"Familial hypercholesterolemia","volume":"33","author":"Bouhairie","year":"2015","journal-title":"Cardiol Clin"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.3390\/ijms21062178","article-title":"Paraneoplastic dermatoses: a brief general review and an extensive analysis of paraneoplastic pemphigus and paraneoplastic dermatomyositis","volume":"21","author":"Didona","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"09","DOI":"10.1590\/s0365-05962013000100001","article-title":"Paraneoplastic cutaneous manifestations: concepts and updates","volume":"88","author":"Silva","year":"2013","journal-title":"An Bras Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.clindermatol.2010.09.022","article-title":"Cutaneous paraneoplasia","volume":"29","author":"Ramos-e-Silva","year":"2011","journal-title":"Clin Dermatol"},{"key":"ref24","volume-title":"StatPearls","author":"Foss","year":"2023"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/ijd.13947","article-title":"A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema","volume":"57","author":"Tolliver","year":"2018","journal-title":"Int J Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"9053","DOI":"10.1038\/s41598-022-12882-2","article-title":"Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1093\/rheumatology\/keaa807","article-title":"Diagnostic delay in autoimmune disease: a systematic review","volume":"60","author":"Zhao","year":"2021","journal-title":"Rheumatology"},{"key":"ref28","volume-title":"StatPearls","author":"Adil","year":"2023"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/sjopt.sjopt_216_24","article-title":"Beh\u00e7et\u2019s disease: a review of the ophthalmologic findings reported in Beh\u00e7et\u2019s original descriptions","volume":"39","author":"Accorinti","year":"2025","journal-title":"Saudi J Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/imr.12369","article-title":"Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo","volume":"269","author":"Harris","year":"2016","journal-title":"Immunol Rev"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e69095","DOI":"10.7759\/cureus.69095","article-title":"Updates on the association between vitiligo and thyroid diseases: a systematic review","volume":"16","author":"Abuhalimeh","year":"2024","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/biomedicines12081839","article-title":"Extraintestinal manifestations in inflammatory bowel disease: from pathophysiology to treatment","volume":"12","author":"Faggiani","year":"2024","journal-title":"Biomedicine"},{"key":"ref35","volume-title":"StatPearls","author":"Malik","year":"2025"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.clindermatol.2010.09.021","article-title":"Skin signs of systemic diseases","volume":"29","author":"Rigopoulos","year":"2011","journal-title":"Clin Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index: a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1828524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:21:09Z","timestamp":1785385269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1828524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1828524"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1828524","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1828524"}}